Cite
HARVARD Citation
Khalique, H. et al. (2021). Oncolytic herpesvirus expressing PD-L1 BiTE for cancer therapy: exploiting tumor immune suppression as an opportunity for targeted immunotherapy. Journal for immunotherapy of cancer. 9 (4), p. . [Online].